For
UK
audiences
The essential guide to product selection
The essential guide to product selection
Non-greasy, emollient barrier cream and wash-off soap substitute for the face and body. Formulated without sulfates, fragrance or colours. Regular use can break the dry skin cycle and maintain the smoothness of the skin by preventing moisture loss and restoring skin barrier function.
Hydrates and softens dry skin with a fragrance-free, color-free formula. It soothes as a moisturiser and doubles as a soap substitute or bath additive.
Soothes and hydrates dry skin and lips, restoring smoothness and softness by retaining moisture.
The biologic abrocitinib is a janus kinase (JAK)1 inhibitor. JAKs are intracellular enzymes which transmit signals arising from cytokine or growth factor-receptor interactions on the cellular membrane to influence cellular processes of haematopoiesis and immune cell function. JAKs phosphorylate and activate Signal Transducers and Activators of Transcription (STATs) which modulate intracellular activity including gene expression. Inhibition of JAK1 modulates the signalling pathways by preventing the phosphorylation and activation of STATs.
Water-based gel containing 0.75% w/w of the active ingredient metronidazole, an antiprotozoal and antibacterial agent used to control infection and inflammation in skin problems.
Acitretin is a retinoid. Retinol (Vitamin A) is known to be essential for normal epithelial growth and differentiation, though the mode of this effect is not yet established. Both retinol and retinoic acid are capable of reversing hyperkeratotic and metaplastic skin changes. However, these effects are generally only obtained at dosages associated with considerable local or systemic toxicity. Acitretin, a synthetic aromatic derivative of retinoic acid, has a favourable therapeutic ratio, with a greater and more specific inhibitory effect on psoriasis and disorders of epithelial keratinisation. The usual therapeutic response to acitretin consists of desquamation (with or without erythema) followed by more normal re-epithelialisation. Acitretin is the main active metabolite of etretinate.
Acnecide is a 5% preparation of benzoyl peroxide, which is an established and effective keratolytic agent with antibacterial properties. It has been shown to be effective in reducing the local population of Propionibacterium acnes, leading to a reduction in the production of irritant fatty acids in the sebaceous glands
A cutaneous solution containing 5 mg of fluorouracil and 100 mg of salicylic acid per 1g of solution.
100% Manuka honey 20g tube
Biosimilar of adalimumab (Humira).